Data in ER-negative cancer cell lines demonstrate that activation of GR drives mammary tumor growth [9] and initiates cell-survival pathways under otherwise apoptosis-inducing conditions such as chemotherapy [8, 10]. Here, NR3C1 is linked to breast cancer.